ARDS & mechanical ventilation
Lung-protective ventilation, proning, neuromuscular blockade and VV-ECMO.
- Trials
- 11
- Years
- 2000–2022
Sort
- 2022RECOVERY-RSOxygenation strategyIn 1,273 patients with COVID-19 acute hypoxaemic failure, CPAP reduced intubation or death versus conventional oxygen, while HFNO did not.36.3% vs 44.4%Read →
- 2019ROSENeuromuscular blockadeIn 1,006 patients with moderate–severe ARDS on high PEEP, early cisatracurium did not reduce 90-day mortality versus light sedation.42.5% vs 42.8%Read →
- 2018EOLIAECMOIn 249 patients with very severe ARDS, early VV-ECMO did not significantly reduce 60-day mortality versus conventional ventilation with rescue ECMO.RR 0.7695% CI 0.55-1.04Read →
- 2015FLORALIOxygenation strategyIn 310 patients with acute non-hypercapnic hypoxaemic respiratory failure, high-flow nasal oxygen improved 90-day mortality compared with standard oxygen or NIV.Read →
- 2013PROSEVA CoreProne positioningIn 466 patients with severe ARDS (P/F <150), early prone positioning ≥16 h/day reduced 28-day mortality compared with supine ventilation.HR 0.3995% CI 0.25-0.63Read →
- 2013OSCILLATEHFOVIn 548 patients with moderate–severe ARDS, high-frequency oscillatory ventilation increased in-hospital mortality compared with low-tidal-volume ventilation.47% vs 35%Read →
- 2010ACURASYSNeuromuscular blockadeIn 340 patients with severe ARDS within 48 hours, 48-hour cisatracurium infusion reduced 90-day mortality compared with placebo.HR 0.6895% CI 0.48-0.98Read →
- 2009CESARECMOIn 180 patients with severe respiratory failure, transfer to an ECMO centre improved 6-month survival without severe disability versus continued conventional care.RR 0.69Read →
- 2006FACTTFluid strategyIn 1,000 patients with ARDS, a conservative fluid strategy did not change 60-day mortality versus a liberal strategy, but increased ventilator-free days.25.5% vs 28.4%Read →
- 2004ALVEOLIPEEP strategyIn 549 patients with ARDS, a higher PEEP strategy did not reduce in-hospital mortality compared with a lower PEEP strategy.24.9% vs 27.5%Read →
- 2000ARMA CoreLung-protective ventilationIn 861 patients with ARDS, 6 mL/kg tidal-volume ventilation reduced in-hospital mortality compared with 12 mL/kg.31.0% vs 39.8%Read →